Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Butler CC, Hobbs FDR, Gbinigie OA, et al. Lancet. 2023 Jan 28;401(10373):281–93. DOI: 10.1016/S0140-6736(22)02597-1
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)